Dr Karen Greenhorn Bingley medical Practice. See Cases.

Slides:



Advertisements
Similar presentations
Type 2 diabetes Implementing NICE guidance 2009 NICE clinical guideline 87.
Advertisements

A Resource for Glycaemic management in Type 2 DM Hypoglycaemia is dangerous: Beware in Elderly/RF/CVS risk Sulphonureas need education to avoid risk Do.
A Resource for Glycaemic management in Diabetes key messages Hypoglycaemia is dangerous: Beware in elderly/RF/CVS risk Sulphonylureas need education to.
Diabetes and Hypothyroidism
Emma Harris Medicines Management Pharmacist West Suffolk Clinical Commissioning Group Educational Event 28 th January 2014 West Suffolk Hospital Education.
Diabetes – sick day rules. Scenario Katie is a 15 year old girl with diabetes 3 day history of cough productive of green sputum, shortness of breath and.
Monitoring diabetes Diabetes Outreach (March 2011)
 GLP -1 (gut hormone) + GIP = incretin effect =Augmentation of insulin after oral glucose  Type 2 diabetics little incretin effect  Reduced GLP-1 secretion.
The New HbA1c HbA1c – DCCT (%) HbA1c – IFFC (mmol/mol)
DIABETES WORKSHOP IN GENERAL PRACTICE Dr John Rochford GP Sharnbrook.
Diabetes for the AKT September We reproduce below our feedback from AKT 16 which sadly continues to apply in AKT 17. Please re-read! “In the last.
Dr Esther Tsang August 2011 Management of Diabetes Mellitus.
Diabetes in the Holy Month of Ramadan Dr. M.K. Abedi.
Dr Kiran Sodha Patient Participation Group October 2014
COMMON LIFESTYLE DISEASES
Nice Guidelines : Diabetes in Pregnancy GP VTS March 09.
Diabetic Nephropathy Case Presentations. UA (Urine Dipstick) Use as an initial screen for all patients Negative to trace proteinuria requires further.
Hba1c for diagnosis Dr Karen Adamson. β-chain α-chain Glucose bound to N-terminal valine of β-chain.
Case Studies on Insulin Initiation
Clinical Biochemistry FAQ for GP Trainees Dr Mourad Labib Consultant Chemical Pathologist DGOH NHS Foundation Trust July 2009.
DIABETES MELLITUS DR. J. PRATHEEBA DEVI. Definition Definition Diabetes is a metabolic disorder characterized by raised levels of glucose in the blood.
DIABETES MELLLITUS Strategies for Achieving Control in an Office Setting.
Drugs used in Diabetes Dr Sally Hudson. BIGUANIDES reduce output of glucose from the liver and enhances uptake and use of glucose by muscle cells ExampleADVANTAGESDISADVANTAGESCOSTCaution.
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
Tutorial 1 Introduction to Endocrine physiology. Case 1  History Salma is a 35 year old lady presented to her doctor with the following symptoms; intolerance.
Oral Hypoglycemic Drugs
Clinical Update in Type 2 Diabetes A Case Discussion Dr. Yancey R. Holmes, MD, FACE Ohio Valley Endocrinology.
Journal Club 2009 年 1 月 29 日(木) 8 : 20 ~ 8 : 50 B 棟 8 階カンファレンスルーム 薬剤部 TTSP 石井 英俊.
Oral hypoglycemic drugs Prof. Mohammad Alhumayyd.
Diabetes mellitus (DM), also known simply as diabetes, is a group of metabolic diseases in which there are high blood sugar levels over a prolonged period.
Chronic elevation of blood glucose levels leads to the endothelium cells taking in more glucose than normal damaging the blood vessels. 2 types of damage.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
Human Physiology Endocrine Glands Chapter 8. Hypothalamus and Pituitary A 50 year-old and has a pituitary tumor that produces excess amounts of growth.
Pharmacology of Diabetes Mellitus 2 Dr Emma Baker Consultant Physician/Senior Lecturer in Clinical Pharmacology.
January 2013 Webinar: “Practical Ways to Help Get Our Diabetes Patients to Goal” Controlling the ABC’s Cases.
 Provide a high level overview of diabetes head to toe.  Discuss the importance of keeping A1Cs under 8.  Identify ways to prevent long-term complications.
NICE/BHS Hypertension Guideline Review 28 June 2006 John Barker ESH Clinical Hypertension Specialists European Society of Hypertension Specialist Accreditation.
Oral hypoglycemic drugs
#4 Management of Diabetes Mellitus. 5 Components of Diabetes Management 5 Components of Diabetes Management Farrell, M. (2005). Textbook of Medical-Surgical.
Oral Diabetes Medications Carol Cordy, MD. Goals Understand how type 2 diabetes affects many organs and how this changes over the course of the illness.
1 ‘Medicines used in the management of Type 2 Diabetes’ Dr Susan McGeoch, Specialist Registrar in Diabetes Sandra Wilson, Diabetes Specialist Nurse.
Insulin Optimisation Workshop Theingi Aung & Claire Rowell.
Journal Club 9/15/11 Sanaz Sakiani, MD 1 st Year Endocrine Fellow Combining Basal Insulin Analogs with Glucagon-Like Peptide-1 Mimetics.
Diabetic Profile Measurement of Blood Glucose T.A. Bahiya Osrah.
Do Now (no sheet today) Pick up a laptop for yourself Open school website.
Do Now (3 min) Turn in your HW (Diabetes article questions, test corrections) Answer the following: 1.What do you know about diabetes? 2.What are some.
Copyright © 2005 by Elsevier Inc. All rights reserved. Slide 1 Chapter 4 Diseases and Conditions of the Endocrine System Copyright © 2005 by Elsevier.
Case discussion Stephen Lo. Case 1  21 year old female presents to the ED with abdominal pain. You attend as part of the medical emergency team at resus,
Dr Sheetal Saggar GP.  Bolton Diabetic Centre ◦ Consultants (4) ◦ Specialist Nurses (8) ◦ Podiatry ◦ Dietetics  General Practice ◦ Structure of diabetic.
A two stage screening process – the pre-diabetes pathway.
GLP-1 agonists Ian Gallen Consultant Community Diabetologist
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Drugs for Type 2 Diabetes – where next after metformin ?
Diabetes & Driving- DVLA rules
Diabetes Learning Event 7th October 2016
Diabetes in Older People :
GLP-1 Agonist:When to start ?
Recurrent falls in an older woman with diabetes
Estimation of blood glucose in diabetes mellitus
Multisystem.
6.Fat- increased lipolysis, inc FFA
Patients aged 85yrs and over
Monitoring in Type 2 Diabetes
Primary Care Diabetes Dr Bruce Davies 02/01/2019.
Primary Care Diabetes Dr Bruce Davies 02/01/2019
Hba1c for diagnosis Dr Karen Adamson.
Diabetes Specialist Nurses
Diabetes Mellitus in Primary Care
Obesity Eppie Habashi.
Priorities for Type 2 Diabetes
Presentation transcript:

Dr Karen Greenhorn Bingley medical Practice

See Cases

Aims and Objestives Accurately Diagnose Diabetes Know Management options for treating Type 2 Diabetes Know the DVLA Guidance for Diabetes Aware of other endocrine problems and how to management them.

HBA1c >6.5% Can be used to Diagnose Diabetes BUT WHO states ‘The diagnosis of diabetes in an asymptomatic person should not be made on the basis of a single abnormal plasma glucose or HbA1c value.’ At least one additional HbA1c > 6.5% or a fasting plasma glucose > 7.0 or a random (casual) sample > 11.1 or from the oral glucose tolerance test (OGTT) It is advisable to use one test or the other but if both glucose and HbA1c are measured and both are “diagnostic” then the diagnosis is made. If one only is abnormal then a further abnormal test result, using the same method, is required to confirm the diagnosis.’ A value of less than 6.5% does not exclude diabetes

Interpreting the Oral Glucose Tolerance Test Impaired fasting glycaemia fasting sample of 6.1mmol/l to 6.9 mmol/l Impaired Glucose Tolerance 2–hour plasma glucose ≥7.8 and <11.1mmol/l Beware this comes back as normal in the pathology links Diabetic 2-hour plasma glucose >11.1mmol/l

Newly Diagnosed Type 2 Diabetic The 42 year old Asian gentleman with a random glucose of 11.6 and a fasting of 7.2

Management BP BMI Bloods (U+E, LFT, HBA1c, Lipids, TFT’s) Urine (ACR) Referral for retinal Screening Referral to EXPERT or dietitian Pulses, 10g monofilament testing and referral to podiatrist

Results BP168/92mmHg BMI37 HBA1c75mmol/mol (9.0%) Cholesterol6.7 ACR4.7

NICE Targets HbA1c<6.5% BP<140/80 mmHg, but if kidney, eye or cerebrovascular disease <130/80 LipidsCholesterol <4.0 mmol/l, LDL <2.0mmol/l

Metformin and Renal Impairment >60, continue 60-45, continue but monitor renal function more frequently (3-6/12) 30-44, prescribe with caution and use 50% of the dose, monitor renal function every 3/12, don’t initiate. <30 absolute contraindication. Stop if on it.

Management Case 2 A 67 year old lady with a BMI of 37 is taking maximum doses of metformin and ramipril and she is unable to exercise due to osteoarthritis of both her knees, comes to the diabetic clinic for the results of her blood tests. HBA1c 62mmol/mol (7.8%) BP 156/88 Other bloods OK What are her options?

Incretin Effect Incretin hormones (GLP1 and GIP) produced by GI tract in response to nutrient entry. Stimulates post-prandial secretion of insulin Suppresses post-prandial secretion of glucogon (reduces gluconeogenesis) Promotes satiety and reduces appetite.

DPP4 Inhibitors (Sitagliptin, Vildagliptin, saxagliptin) Inhibits the breakdown of GIP by inhibiting the enzyme DPP4 Licensed for any triple therapy. And can be used with insulin. Once daily tablet. (up to bd with vildagliptin) More effective if used early in the course of diabetes. Avoid if eGFR <50 S/E Headache. URTI. Weight neutral.

Incretin Mimetics (Exenatide and Liraglutide) GLP 1 Analogue It interacts with a specific receptor on the beta cell. Helps weight loss Sub cut injection (as rapidly degraded in the circulation) 60 minutes before meals. BD for exenatide, and (new once weekly), OD for Liraglutide

GLP1 Analogues (Exenatide, Liraglutide) Exenatide licensed triple therapy with sulphonylurea and metformin, Liraglutide triple therapy can also include a Glitazone. NOT licensed for monotherapy. NICE : HbA1c >7.5% and BMI > 35 in people of European decent or lower BMI (>30) if other ethnicity or weight loss would benefit other co-morbidities. eGFR avoid if <30 exenatide, <60 Liraglutide. S/E nausea very common. Hypoglycaemia more common if taken with a sulphonylurea. Acute pancreatitis.

Weight Loss Surgery Reuxen-Y-Bipass better than banding (can now be done laparoscopically) On average 82% REMISSION FROM DIABETES 14 years post surgery The greater the BMI the greater the benefit BUT Leads to malabsorption problems (B12, Calcium, anaemia), gastric dumping syndrome and rarely hypoglycaemia

Case 3 48 year old gentleman recently diagnosed with type 2 diabetes and has been to see the dietician who is concerned with the amount he is having to eat to maintain his weight and is concerned that he is actually a type 1 diabetic. He is on the maximum dose of glimepiride and HBA1c is 90mmol/mol (10.4). He feels well, what do you do?

Blood Glucose monitoring Type 1 or type 2 on intensive insulin regime. Pregnancy on insulin. QDS Type 2 on conventional insulin therapy. 2-3 times a week, more if not stable or unwell. Type 2 on insulin and Oral hypoglycaemics. At least OD varying the times. Type 2 on sulphonyluria.Only to identify hypo’s Diet alone or metformin or glitazone. DO NOT NEED. In motivated can be used to monitor lifestyle changes.

Case 4 A 28 year old Type 1 Diabetic has come for a medication review as he has been ordering a lot more strips recently, 2 boxes of 50 a week. On discussion he had become obsessed about having a hypo having been in hospital recently with a hypoglycaemic episode. His partner had treated it using hypostop gel and he was admitted for a few hours observation in hospital. He drives to work, what conversation should you have with him?

Severe hypoglycaemia Defined as requiring the assistance of another person. Changes to the standards for driving Group 1 vehicles (cars and motorcycles) The following changes introduced by the European Union have applied since September Must NOT have had more than one episode of severe hypoglycaemia within the preceding 12 months Must NOT have impaired awareness of hypoglycaemia which has been defined by the Diabetes Panel for Group 1 vehicles as an inability to detect the onset of hypoglycaemia because of a total absence of warning symptoms Further information can be obtained from the DVLA website –

Driving and Hypoglycaemia Must Test Blood Glucose before Driving If <4.0 MUST NOT DRIVE If <5.0 Have a snack before driving Check Blood Glucose every 2 hours when driving If having a Hypo must pull over, take keys out of ignition and sit in passenger seat for 45 minutes after it has been corrected.

Case 5 This 70 year old gentleman has recently been diagnosed with diabetes, what investigations should you do?

Cushing Syndrome

Cushings Syndrome Glucocorticoid excess Primary excess due to Adrenal adenoma/carcinoma Increased ACTH due to Pituitary or ectopic source. TEST U+E, Dexamethasone suppression test (1mg Dex at 11pm, no suppression), 24 hour free cortisol, CXR.

Case 6 A 32 year old lady has been complaining of being tired all the time! But also legs feel very weak, as though is going to pass out all the time and been loosing weight. What blood tests would you do if any?

Blood results FBC normal Glucose 4.2mmol/l Sodium 125mmol/l Potassium 6.2mmol/l Urea 10mmol/l Normal creatinine What is the diagnosis and what do you do?

Addison’s Disease Primary Hypoadrenalism and ACTH excess

Secondary Hypoadrenalism Long term steroid use Inadequate ACTH production (panhypopituitarism)

Case 7 A 48 year old lady is complaining of feeling tired all the time, difficulty loosing weight and dry skin. You do some blood tests which are all normal apart from a TSH of 7.8 and normal T4 What do you do?

Overt Hypothyroisim Symptomatic TSH >10 Reduced serum free or total thyroxine

Sub-clinical Hypothyroidism TSH 5-10 Normal Thyroxine levels Whether to treat is controversial EXCEPT IN PREGNANCY or trying to conceive. Risk of progression to overt is small (5% pa with antibodies, 2% pa without)

When to Treat IF SYMPTOMS trial of thyroxine for 6 months, if feel better can continue (50%). NO SYMPTOMS BUT ANTIBODIES not to treat but yearly surveillance.